Liposomal cancer chemotherapy: current clinical applications and future prospects
- 1 June 2001
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 10 (6), 1045-1061
- https://doi.org/10.1517/13543784.10.6.1045
Abstract
(2001). Liposomal cancer chemotherapy: current clinical applications and future prospects. Expert Opinion on Investigational Drugs: Vol. 10, No. 6, pp. 1045-1061. doi: 10.1517/13543784.10.6.1045Keywords
This publication has 68 references indexed in Scilit:
- Phase II Study of Liposomal Doxorubicin in Advanced Gynecologic CancersGynecologic Oncology, 2000
- Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar(PSC 833) with sterically stabilized liposomal doxorubicinInternational Journal of Cancer, 1999
- GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinideInternational Journal of Cancer, 1999
- Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma modelInternational Journal of Cancer, 1999
- Liposomal distribution in malignant gliomaNuclear Medicine Communications, 1997
- MDR1 gene expression in solid tumoursEuropean Journal Of Cancer, 1996
- Chromatographic Analysis and Pharmacokinetics of Liposome-Encapsulated Doxorubicin in Non-Small-Cell Lung Cancer PatientsJournal of Pharmaceutical Sciences, 1993
- Effect of liposomes on P-glycoprotein function in multidrug resistant cellsBiochemical and Biophysical Research Communications, 1992
- MDR1 gene expression and prognostic factors in primary breast carcinomasEuropean Journal of Cancer and Clinical Oncology, 1991
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965